Adaptimmune Therapeutics PLC ADAPY
OTC · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2015-05-06
Adaptimmune Therapeutics PLC institutional holders (13F)
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 193,757 | $188,894 | 0.01% |
% of company = reported 13F shares ÷ shares outstanding. Based on the latest filings; not every holder reports every quarter.
Source: SEC EDGAR filings · CIK 0001621227 · US · as of 2024-12-31. facts plus Stocktoria's own computed scores — not investment advice.